These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 18789878

  • 21. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.
    Kitamura H, Torigoe T, Honma I, Asanuma H, Nakazawa E, Shimozawa K, Hirohashi Y, Sato E, Sato N, Tsukamoto T.
    Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519
    [Abstract] [Full Text] [Related]

  • 22. Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts.
    Jandus C, Bioley G, Dojcinovic D, Derré L, Baitsch L, Wieckowski S, Rufer N, Kwok WW, Tiercy JM, Luescher IF, Speiser DE, Romero P.
    Cancer Res; 2009 Oct 15; 69(20):8085-93. PubMed ID: 19808957
    [Abstract] [Full Text] [Related]

  • 23. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
    Kim EK, Cho HI, Yoon SH, Park MJ, Sohn HJ, Kim HJ, Oh ST, Kim TG.
    Vaccine; 2008 Jul 29; 26(32):3987-97. PubMed ID: 18584926
    [Abstract] [Full Text] [Related]

  • 24. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
    Eto M, Kodama S, Uemura N, Suzuki M.
    Head Neck; 2007 Dec 29; 29(12):1128-35. PubMed ID: 17636541
    [Abstract] [Full Text] [Related]

  • 25. Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    Am J Obstet Gynecol; 2009 Jan 29; 200(1):75.e1-10. PubMed ID: 18976739
    [Abstract] [Full Text] [Related]

  • 26. Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
    Tsuji T, Altorki NK, Ritter G, Old LJ, Gnjatic S.
    J Immunol; 2009 Oct 01; 183(7):4800-8. PubMed ID: 19734225
    [Abstract] [Full Text] [Related]

  • 27. Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin.
    Otto K, Andersen MH, Eggert A, Keikavoussi P, Pedersen LØ, Rath JC, Böck M, Bröcker EB, Straten PT, Kämpgen E, Becker JC.
    Vaccine; 2005 Jan 04; 23(7):884-9. PubMed ID: 15603888
    [Abstract] [Full Text] [Related]

  • 28. Dendritic cells with transduced survivin gene induce specific cytotoxic T lymphocytes in human urologic cancer cell lines.
    Kikkawa K, Fujii R, Kuramoto T, Mori T, Inagaki T, Kohjimoto Y, Iwahashi M, Yamaue H, Hara I.
    Urology; 2009 Jul 04; 74(1):222-8. PubMed ID: 19285711
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Preta G, Marescotti D, Fortini C, Carcoforo P, Castelli C, Masucci M, Gavioli R.
    Scand J Immunol; 2008 Dec 04; 68(6):579-88. PubMed ID: 19000094
    [Abstract] [Full Text] [Related]

  • 30. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.
    Yie SM, Lou B, Ye SR, He X, Cao M, Xie K, Ye NY, Lin R, Wu SM, Xiao HB, Gao E.
    Lung Cancer; 2009 Feb 04; 63(2):284-90. PubMed ID: 18606477
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J, Hirohashi Y, Torigoe T, Michifuri Y, Yamamoto T, Tamura Y, Kamiguchi K, Miyazaki A, Yamaguchi A, Hariu H, Hiratsuka H, Sato N.
    Hum Immunol; 2009 Feb 04; 70(2):89-95. PubMed ID: 19124056
    [Abstract] [Full Text] [Related]

  • 33. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
    Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J.
    Scand J Immunol; 2009 Apr 04; 69(4):319-28. PubMed ID: 19284496
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
    Zhou Q, Guo AL, Xu CR, An SJ, Wang Z, Yang SQ, Wu YL.
    Clin Exp Immunol; 2008 Sep 04; 153(3):392-400. PubMed ID: 18803763
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
    Carlsson B, Sadeghi A, Bengtsson M, Wagenius G, Tötterman TH.
    J Immunother; 2008 Sep 04; 31(7):633-43. PubMed ID: 18600181
    [Abstract] [Full Text] [Related]

  • 39. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S.
    Oncol Rep; 2008 Jul 04; 20(1):155-63. PubMed ID: 18575732
    [Abstract] [Full Text] [Related]

  • 40. Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing Tumors.
    Bioley G, Guillaume P, Luescher I, Bhardwaj N, Mears G, Old L, Valmori D, Ayyoub M.
    J Immunother; 2009 Jul 04; 32(2):161-8. PubMed ID: 19238015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.